Carlo Marchetti

University of Colorado Anschutz Medical Campus

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment”.

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0065

N/A

0.488DataRank · unranked

16 citations

Adrian T.A. Dominguez, Shaikh M. Atif, Alberto Dinarello, Tania Azam, Kibrom M. Alula +11 more

Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis

Frontiers in Physiology(2020)10.3389/fphys.2020.00396

N/A

0DataRank · unranked

24 citations

Lyla A. Youssef, Julie A. Reisz, Monika Dzieciątkowska, Nicholas E. Powers, Carlo Marchetti +7 more

Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2000915118

N/A

0DataRank · unranked

194 citations

Dinoop Ravindran Menon, Douglas G. Osborne, C. Preston Neff, Nicholas E. Powers, Fabia Gamboni +17 more

Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression

Frontiers in Immunology(2021)10.3389/fimmu.2021.661323

N/A

0DataRank · unranked

127 citations

Alberto Dinarello, Nicholas E. Powers, Matthew A. Burchill, Leo A. B. Joosten, Carlo Marchetti +2 more

Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers

Pharmaceuticals(2022)10.3390/ph15050574

N/A

0DataRank · unranked

23 citations

Suzhao Li, Nicholas E. Powers, Makenna May, C. Preston Neff, Leo A. B. Joosten +3 more

IL-38 Gene Deletion Worsens Murine Colitis

Frontiers in Immunology(2022)10.3389/fimmu.2022.840719

N/A

0DataRank · unranked

16 citations

Ruth X. Wang, Jesús Amo‐Aparicio, J. Scott Lee, Alexander S. Dowdell, Isak W. Tengesdal +5 more

NLRP3 and cancer: Pathogenesis and therapeutic opportunities

Pharmacology & Therapeutics(2023)10.1016/j.pharmthera.2023.108545

N/A

0DataRank · unranked

49 citations

Charles A. Dinarello, Carlo Marchetti, Isak W. Tengesdal

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30065-5

N/A

0DataRank · unranked

296 citations

Tim Jansen, M. Janssen, Antoaneta Comarniceanu, M. Efdé, Isak W. Tengesdal +8 more

IL-38 regulates intestinal stem cell homeostasis by inducing WNT signaling and beneficial IL-1β secretion

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2306476120

N/A

0DataRank · unranked

7 citations

Makenna May, Jesús Amo‐Aparicio, Tania Azam, Joseph M. Gaballa, Carlo Marchetti +10 more